Medical Device News Magazine

Aspen Surgical Products Acquires Stork® Labor and Delivery Products

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Aspen Surgical Products, Inc. (“Aspen”), a leader in surgical disposable products, announced the acquisition of Stork® (“Stork”), a division of Briggs Healthcare.
Founded in 1958, the Stork line of products includes high-quality, branded sterile disposable obstetric products, such as the Plastibell® Disposable Circumcision Device, the Amnihook® Amniotic Membrane Perforator, the Double-Grip® Umbilical Cord Clamp, the Umbilical Cord Clamp® Clipper, the U-Bag® Pediatric Urine Collection Bag, and the Ready-Rolled® FootPrinter. The acquisition of Stork strengthens Aspen’s broad portfolio of medical and surgical disposables sold into the acute care market.

“The Stork branded products have been a market leader in the labor and delivery space for over 50 years,” said Jason Krieser, CEO of Aspen. “The line fits very well with our current operational and commercial infrastructure, and we believe it is a sound platform for future growth in the obstetrics and gynecology space.”

“Including Stork, we have completed five acquisitions in the last 18 months,” Jason continued. “This, along with our internal manufacturing investments, commercial enhancements, and new product introductions, has helped us improve and expand our portfolio, providing more value to both our distribution partners and our end-user customers.”

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”